Study Comparing Immune Response to, and Safety of, Fluviral and Fluzone Influenza Vaccines in Persons 50 y.o. and Over

NCT00232947 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

900

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Influenza virus vaccine (Fluviral)
BIOLOGICAL: Influenza virus vaccine (Fluzone)

Sponsor

ID Biomedical Corporation, Quebec